These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 43252)

  • 1. Species differences in the metabolism of pamatolol, a cardioselective beta--adrenoceptor antagonist.
    Hoffmann KJ; Skånberg I; Borg KO
    Eur J Drug Metab Pharmacokinet; 1979; 4(3):163-73. PubMed ID: 43252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the metabolism of the beta-adrenoceptor antagonists alprenolol, metoprolol and pamatolol.
    Hoffmann K
    Acta Pharm Suec; 1979; 16(2):160. PubMed ID: 38629
    [No Abstract]   [Full Text] [Related]  

  • 3. Pamatolol: phase I evaluation of the pharmacodynamics of a cardioselective beta adrenoceptor blocking drug.
    Carruthers SG; Hosler JP; Pentikainen P; Azarnoff DL
    Clin Pharmacol Ther; 1978 Aug; 24(2):168-74. PubMed ID: 28193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).
    Goldaniga G; Montesanti L; Pianezzola E; Valzelli G
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):9-20. PubMed ID: 6104601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
    Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J; Smith RP; Ferguson RA
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic disposition of the selective beta 1-adrenoceptor agonist prenalterol in mice, rats, dogs, and humans.
    Hoffmann KJ; Arfwidsson A; Borg KO
    Drug Metab Dispos; 1982; 10(2):173-9. PubMed ID: 6124405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of pamatolol, a cardioselective beta adrenoreceptor blocker.
    Carruthers SG; Pentikainen P; Hosler JP; Azarnoff DL
    Clin Pharmacol Ther; 1979 Dec; 26(6):682-5. PubMed ID: 40725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of the beta-adrenergic-blocking agent, nadolol, by mice, rats, hamsters, rabbits, dogs, monkeys, and man: an unusual species difference.
    Dreyfuss J; Shaw JM; Ross JJ
    Xenobiotica; 1978 Aug; 8(8):503-8. PubMed ID: 29379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of carvedilol in dogs, rats, and mice.
    Schaefer WH; Politowski J; Hwang B; Dixon F; Goalwin A; Gutzait L; Anderson K; DeBrosse C; Bean M; Rhodes GR
    Drug Metab Dispos; 1998 Oct; 26(10):958-69. PubMed ID: 9763400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of exaprolol from the in-situ gastrointestinal tract of rats and dogs.
    Motheová O; Zemánek M; Faberova V; Trnovec T; Gabauer I; Styk J; Durisová M; Nosálová V
    J Pharm Pharmacol; 1985 Nov; 37(11):816-9. PubMed ID: 2867165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of talinolol metabolites in urine of man, dog, rat and mouse after oral administration by high-performance liquid chromatography-thermospray tandem mass spectrometry.
    Schupke H; Hempel R; Eckardt R; Kronbach T
    J Mass Spectrom; 1996 Dec; 31(12):1371-81. PubMed ID: 8990520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of the beta-blocker 14C-bupranolol in humans, dogs, and rhesus monkeys.
    Waller AR; Chasseaud LF; Bonn R; Taylor T; Darragh A; Girkin R; Down WH; Doyle E
    Drug Metab Dispos; 1982; 10(1):51-4. PubMed ID: 6124383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of amlodipine in the rat and the dog: a species difference.
    Beresford AP; Macrae PV; Stopher DA
    Xenobiotica; 1988 Feb; 18(2):169-82. PubMed ID: 2967592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species differences in the metabolism of alpha-1-trans-4-dimethylaminotetrahydro-3-furyl-cyclohexanephenylglycolate, an experimental anticholinergic agent.
    Sullivan HR; Page JG; Due SL
    Biomed Mass Spectrom; 1975 Feb; 2(1):53-8. PubMed ID: 1131394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
    Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
    Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biotransformation of B 24/76 in the rat, minipig, dog and man].
    Baumann A; Seefeld R; Werner I; Seifert B; Witte M; Pollex S; Grisk A
    Pharmazie; 1989 Mar; 44(3):215-8. PubMed ID: 2568641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.